Time-restricted feeding has a limited effect on hepatic lipid accumulation, inflammation and fibrosis in a choline-deficient high-fat diet-induced murine NASH model

被引:4
作者
Sato, Tomoyuki [1 ]
Oishi, Katsutaka [1 ,2 ,3 ]
机构
[1] Natl Inst Adv Ind Sci & Technol, Cellular & Mol Biotechnol Res Inst, Hlth Food Sci Res Grp, Tsukuba, Japan
[2] Univ Tokyo, Grad Sch Frontier Sci, Dept Computat Biol & Med Sci, Kashiwa, Japan
[3] Tokyo Univ Sci, Grad Sch Sci & Technol, Dept Appl Biol Sci, Noda, Japan
来源
PLOS ONE | 2024年 / 19卷 / 01期
基金
日本学术振兴会;
关键词
NONALCOHOLIC STEATOHEPATITIS; MOUSE MODEL; LIVER; MICE;
D O I
10.1371/journal.pone.0296950
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Nonalcoholic steatohepatitis (NASH) occurs worldwide and is characterized by lipid accumulation in hepatocytes, hepatic inflammation, fibrosis, and an increased risk of cirrhosis. Although a major proportion of NASH patients exhibit obesity and insulin resistance, 20% lack a high body mass and are categorized as "non-obese NASH". Time-restricted feeding (TRF), limiting daily food intake within certain hours, improves obesity, lipid metabolism, and liver inflammation. Here, we determined whether TRF affects NASH pathology induced by a choline-deficient high-fat diet (CDAHFD), which does not involve obesity. TRF ameliorated the increase in epididymal white adipose tissue and plasma alanine transaminase and aspartate transaminase levels after 8 weeks of a CDAHFD. Although gene expression of TNF alpha in the liver was suppressed by TRF, it did not exhibit a suppressive effect on hepatic lipid accumulation, gene expression of cytokines and macrophage markers (Mcp1, IL1b, F4/80), or fibrosis, as evaluated by Sirius red staining and western blot analysis of alpha-smooth muscle actin. A CDAHFD-induced increase in gene expression related to fibrogenesis (Collagen 1a1 and TGF beta) was neither suppressed by TRF nor that of alpha-smooth muscle actin but was increased by TRF. Our results indicated that TRF has a limited suppressive effect on CDAHFD-induced NASH pathology.
引用
收藏
页数:12
相关论文
共 29 条
  • [1] Sudachitin and Nobiletin Stimulate Lipolysis via Activation of the cAMP/PKA/HSL Pathway in 3T3-L1 Adipocytes
    Abe, Tomoki
    Sato, Tomoyuki
    Murotomi, Kazutoshi
    [J]. FOODS, 2023, 12 (10)
  • [2] Impact of intermittent fasting on laboratory, radiological, and anthropometric parameters in NAFLD patients
    Badran, Hanaa
    Elsabaawy, Maha
    Sakr, Ahmed
    Eltahawy, Mahmoud
    Elsayed, Mahitab
    Elsabaawy, Dalia M.
    Abdelkreem, Mervat
    [J]. CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2022, 8 (02) : 118 - 124
  • [3] Western Diet-Fed ApoE Knockout Male Mice as an Experimental Model of Non-Alcoholic Steatohepatitis
    Camargo, Felipe N.
    Matos, Sandro L.
    Araujo, Layanne C. C.
    Carvalho, Carla R. O.
    Amaral, Andressa G.
    Camporez, Joao Paulo
    [J]. CURRENT ISSUES IN MOLECULAR BIOLOGY, 2022, 44 (10) : 4692 - 4703
  • [4] The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
    Chalasani, Naga
    Younossi, Zobair
    Lavine, Joel E.
    Charlton, Michael
    Cusi, Kenneth
    Rinella, Mary
    Harrison, Stephen A.
    Brunt, Elizabeth M.
    Sanyal, Arun J.
    [J]. HEPATOLOGY, 2018, 67 (01) : 328 - 357
  • [5] Time restricted feeding modifies leukocyte responsiveness and improves inflammation outcome
    Ella, Krisztina
    Sudy, Agnes R.
    Bur, Zsofia
    Koos, Bence
    Kisiczki, Armin S.
    Mocsai, Attila
    Kaldi, Krisztina
    [J]. FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [6] Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease
    Estes, Chris
    Razavi, Homie
    Loomba, Rohit
    Younossi, Zobair
    Sanyal, Arun J.
    [J]. HEPATOLOGY, 2018, 67 (01) : 123 - 133
  • [7] Mouse Models of Nonalcoholic Steatohepatitis: Toward Optimization of Their Relevance to Human Nonalcoholic Steatohepatitis
    Farrell, Geoff
    Schattenberg, Jorn M.
    Leclercq, Isabelle
    Yeh, Matthew M.
    Goldin, Robert
    Teoh, Narci
    Schuppan, Detlef
    [J]. HEPATOLOGY, 2019, 69 (05) : 2241 - 2257
  • [8] Mechanisms of NAFLD development and therapeutic strategies
    Friedman, Scott L.
    Neuschwander-Tetri, Brent A.
    Rinella, Mary
    Sanyal, Arun J.
    [J]. NATURE MEDICINE, 2018, 24 (07) : 908 - 922
  • [9] Nonalcoholic Steatohepatitis and HCC in a Hyperphagic Mouse Accelerated by Western Diet
    Ganguly, Souradipta
    Muench, German A. Eman
    Shang, Linshan
    Rosenthal, Sara Brin
    Rahman, Gibraan
    Wang, Ruoyu
    Wang, Yanhan
    Kwon, Hyeok Choon
    Diomino, Anthony M.
    Kisseleva, Tatiana
    Soorosh, Pejman
    Hosseini, Mojgan
    Knight, Rob
    Schnabl, Bernd
    Brenner, David A.
    Dhar, Debanjan
    [J]. CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY, 2021, 12 (03): : 891 - 920
  • [10] Mouse models of nonalcoholic steatohepatitis in preclinical drug development
    Hansen, Henrik H.
    Feigh, Michael
    Veidal, Sanne S.
    Rigbolt, Kristoffer T.
    Vrang, Niels
    Fosgerau, Keld
    [J]. DRUG DISCOVERY TODAY, 2017, 22 (11) : 1707 - 1718